SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Attention centers on Alpha Taus upcoming clinical milestones, especially REGAIN glioblastoma data and progress in its pancreatic cancer program; traders are also watching for a possible FDA path to a larger Keytruda combination study. The community is broadly bullish on the pipeline, while some note that early patient results remain limited and the share price has faced low-volume resistance.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA accelerated approval of a competing treatment for recurrent respiratory papillomatosis has raised concerns about competition for Precigens PAPZIMEOS. Traders debate whether the rivals dosing approach could draw patients away or whether PAPZIMEOSs commercial head start, established coverage and clinical record will help it retain demand.

Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.

Centrus Energy Corp - Ordinary Shares - Class A

Centrus Energy Corp 

Centrus steep decline has focused discussion on dilution from stock-and-warrant offerings and the costly, long-term capacity buildout. Bears question valuation and execution, while bulls argue the financing supports domestic LEU/HALEU production for growing nuclear-fuel demand.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs large equity raise and stock-funded Elisity acquisition have put dilution and capital allocation at the center of discussion as shares weaken. Some traders view the deal as expanding its quantum and cybersecurity platform, while others question the impact on shareholders and whether the acquisitions will deliver value; upcoming earnings are also a focus.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXTs stronger-than-expected quarterly results and upbeat outlook, tied to rising indium phosphide demand, are driving discussion. Despite the positive report, shares have fallen sharply; traders are split between viewing the drop as a buying opportunity and blaming broader tech-sector weakness and market sentiment.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTXs breakout to a fresh 52-week high is drawing attention ahead of its expected quarterly results, with traders focused on BRIUMVIs sales momentum and speculating about a potential buyout or short squeeze. Some see the move as bullish positioning, while others caution that expectations may already be priced in and the earnings timing remains uncertain.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors Nov. 22 FDA target decision on deramiocel for Duchenne muscular dystrophy is driving attention, with traders treating renewed launch-related hiring and a more flexible tone on rare-disease reviews as possible positive signalsnot proof of approval. Debate remains over whether the FDA will grant a narrower upper-limb label or reject the application, given the prior advisory-panel concerns and uncertainty about the efficacy evidence.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intels post-earnings selloff is the dominant topic: traders point to weaker-than-expected fourth-quarter guidance, soft PC demand and supply constraints despite a strong third quarter. The community is divided between buyers calling the drop an overreaction and bearish traders questioning management execution and the companys longer-term prospects.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarnas steep post-earnings decline and persistent share-price weakness dominate discussion, with traders pointing to reduced guidance tied to Germany and concerns about profitability and margins. Some view the selloff as excessive given the companys growth and partnerships, while others expect continued pressure and speculate about short-selling; upcoming earnings are a key focus.

Twilio, Inc. engages in the development of communications software, cloud-based platforms, and services. It operates through Twilio Communications and Twilio Segments. The Twilio Communications segment includes the platforms Messaging and Voice. The Twilio Segment involves Segment, Engage, Flex, Email, and others. The company was founded by John Wolthuis, Jeffery G. Lawson, and Evan Cooke in March 2008 and is headquartered in San Francisco, CA.

Twilio Inc - Ordinary Shares Class A

Twilio Inc

Twilios Q3 results beat expectations and its full-year outlook rose, but weaker Q4 organic-growth guidance signaled a slowdown and drove a sharp selloff. Traders are debating whether the drop is an overreaction to the outlook or a necessary repricing, with some watching for support and others wary of further declines.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aside from  
$MRK 
  
I am interested in $BVS  
and $TLX in the Pharma space 
 
Time to put the learned context to use